The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8956811 B1

PDF
Full Text
Expired
Date of Patent:
Feb. 17, 2015

Filed:

Jul. 15, 2013
Applicant:

Genentech, Inc., South San Francisco, CA (US);

Inventors:

Kang Li, Beijing, CN;

Sek Chung Fung, Gaithersburg, MD (US);

Zhengbin Yao, Berwyn, PA (US);

Assignee:

Genentech Inc., South San Francisco, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C07K 16/18 (2006.01); C07K 16/28 (2006.01); G01N 33/50 (2006.01); G01N 33/53 (2006.01); G01N 33/574 (2006.01); G01N 33/577 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57492 (2013.01); C07K 16/28 (2013.01); G01N 33/574 (2013.01); G01N 33/57488 (2013.01); C07K 2317/56 (2013.01); G01N 2333/705 (2013.01);
Abstract

The present invention relates to novel antibodies that bind specifically to human Notch 3 and their use in the detection and/or diagnosis of Notch 3 related diseases, such as cancer. The present invention also includes nucleic acids encoding these novel antibodies, vectors and cell lines harboring the nucleic acids, and kits comprising the antibodies for use in the detection and diagnosis.


Find Patent Forward Citations

Li, Kang. (2015). Diagnosis of malignant neoplasms using anti-notch3 antibodies (U.S. Patent No. 8956811). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8956811

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…